1. 1. Budget impact analysis of botulinum neurotoxin a therapy for upper limb spasticity in the United Kingdom. (January 2015) Authors: Abogunrin, Seye; Hortobagyi, Linda; Remak, Edit; Dinet, Jerome; Gabriel, Sylvie; Bakheit, Abdel Magid O. Journal: Toxicon Issue: Volume 93(2015)Supplement Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 10. Molecular basis of immunogenicity to botulinum neurotoxins. (January 2015) Authors: Zouhair Atassi, M. Journal: Toxicon Issue: Volume 93(2015)Supplement Page Start: S4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 100. Children are not little adults—dosage and development do matter. (January 2015) Authors: Heinen, Florian; Berweck, Steffen; Sebastian Schroeder, A. Journal: Toxicon Issue: Volume 93(2015)Supplement Page Start: S30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 101. Genetic diversity among botulinum neurotoxin‒producing bacteria and their neurotoxins. (January 2015) Authors: Hill, Karen K. Journal: Toxicon Issue: Volume 93(2015)Supplement Page Start: S31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 102. Evidence-based review: laryngeal dystonia—abductor, adductor, and vocal tremor. (January 2015) Authors: Hillel, Allen Journal: Toxicon Issue: Volume 93(2015)Supplement Page Start: S31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 103. Thickness of gastrocnemius muscle in ambulatory children with cerebral palsy. (January 2015) Authors: Hong, Bo Young; Sul, Bo Mi; Kim, Joon Sung; Lim, Seong Hoon; Kim, Ha Min Journal: Toxicon Issue: Volume 93(2015)Supplement Page Start: S31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 104. Process development and cGMP manufacture of a targeted secretion inhibitor: a novel botulinum neurotoxin–based biotherapeutic platform. (January 2015) Authors: Hooker, Andy; Splevins, Andrew; Horrocks, Peter Journal: Toxicon Issue: Volume 93(2015)Supplement Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 105. Effect of botulinum neurotoxin type A subtypes on guinea pig isolated ileum smooth muscle. (January 2015) Authors: Hornby, Fraser; Hedley, Diana; Fonfria, Elena; Krupp, Johannes Journal: Toxicon Issue: Volume 93(2015)Supplement Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 106. Safety and effectiveness of incobotulinumtoxinA (Xeomin) in adult subjects with spasticity previously treated with onabolulinumtoxinA (Botox). (January 2015) Authors: Hysa, Viola Q.; Verduzco-Gutierrez, Monica Journal: Toxicon Issue: Volume 93(2015)Supplement Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 107. Infiltration with botulinum neurotoxin A (Xeomin) in flexible intervals to reach appropriate modulation of spasticity. (January 2015) Authors: Ianieri, Giancarlo; Romanelli, E.; Mastromauro, L.; Marvulli, R.; Marzo, G.B. Journal: Toxicon Issue: Volume 93(2015)Supplement Page Start: S33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗